StephenDouglasMalleyMD

PubMed

• 42 citations
  A Comparison of Functional Brain Changes Associated with Surgical Versus Behavioral Weight Loss
  Amanda S. Bruce, Jared M. Bruce, Abigail R. Ness, Rebecca J. Lepping, Stephen Malley, Laura Hancock, Josh Powell, Trisha M. Patrician, Florence J. Breslin, Laura E. Ma...> ;Obesity. 2014 Feb 1
• Selective cytotoxicity of L-glutamic acid gamma-monohydroxamate (GAH) for melanoma tumor cells.
  Thomasset, N., Chabanas, A., Tournaire, R., Malley, S., Navarro, C., Lawrence, J. J., Doré, J. F., Vila, J.> ;Anticancer Res. 1993 Sep 01
• Inhibition of malate-aspartate shuttle by the antitumor drug L-glutamic acid gamma-monohydroxamate in L1210 leukemia cells.
  Thomasset, N., Goetsch, L., Hamedi-Sangsari, F., Tournaire, R., Malley, S., Navarro, C., Doré, J. F., Vila, J.> ;Int J Cancer. 1992 May 8
• Anti-tumoral activity of L and D isomers of aspartic acid beta-hydroxamate on L5178Y leukemia.
  Thomasset, N., Hamedi-Sangsari, F., Tournaire, R., Navarro, C., Malley, S., Goetsch, L., Grange, J., Vila, J.> ;Int J Cancer. 1991 Sep 30
• Therapeutic effects of D-aspartic acid beta-hydroxamate (DAH) on Friend erythroleukemia.
  Tournaire, R., Malley, S., Hamedi-Sangsari, F., Thomasset, N., Grange, J., Dore, J. F., Vila, J.> ;Int J Cancer. 1994 Aug 1
• Antiproliferative effect of D-aspartic acid beta-hydroxamate (DAH) on Friend virus-infected erythropoietic progenitor cells.
  Tournaire, R., Arnaud, S., Hamedi-Sangsari, F., Malley, S., Grange, J., Blanchet, J. P., Doré, J. F., Vila, J.> ;Leukemia. 1994 Oct
• Pilot clinical trial of the combination of hydroxyurea and didanosine in HIV-1 infected individuals.
  Biron, F., Lucht, F., Peyramond, D., Fresard, A., Vallet, T., Nugier, F., Grange, J., Malley, S., Hamedi-Sangsari, F., Vila, J.> ;Antiviral Res. 1996 Jan
• Anti-HIV activity of the combination of didanosine and hydroxyurea in HIV-1-infected individuals.
  Biron, F., Lucht, F., Peyramond, D., Fresard, A., Vallet, T., Nugier, F., Grange, J., Malley, S., Hamedi-Sangsari, F., Vila, J.> ;J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Sep 1
• Synergistic anti-human immunodeficiency virus type 1 effect of hydroxamate compounds with 2',3'-dideoxyinosine in infected resting human lymphocytes.
  Malley, S. D., Grange, J. M., Hamedi-Sangsari, F., Vila, J. R.> ;Proc Natl Acad Sci U S A. 1994 Nov 8
• Suppression of HIV production in resting lymphocytes by combining didanosine and hydroxamate compounds.
  Malley, S. D., Grange, J. M., Hamedi-Sangsari, F., Vila, J. R.> ;Lancet. 1994 May 21
• Join now to see all